Study: Young MJ Consumers With Psychosis Risk Saw Symptom Improvement
A new study, titled “Recreational Cannabis Use Over Time in Individuals at Clinical High Risk for Psychosis: Lack of Associations with Symptom, […]
A new study, titled “Recreational Cannabis Use Over Time in Individuals at Clinical High Risk for Psychosis: Lack of Associations with Symptom, […]
A study published in the journal Molecules on Aug. 20, entitled “Therapeutic Potential of Minor Cannabinoids in Dermatological Diseases—A Synthetic Review,” put […]
Sub-anesthetic ketamine infusions, which are already used for treatment-resistant depression (TRD), may also help people through benzodiazepine withdrawal, new research published in […]
According to a recently published survey in the Journal of Psychoactive Drugs, people in Canada are using psychedelics for therapy, but not […]
Using cannabis is not associated with an increased risk of heart attack among middle-aged adults, according to data published in the American […]
A new study featured online in The International Journal of Drug Policy (which will be included in the September 2023 issue of […]
Researchers at the Tabriz University of Medical Sciences in Iran performed the analysis on “seven studies, containing 11 surveys and 4 cohorts.” […]
Many long-term consumers of cannabis develop higher tolerance over time. And with the array of higher potency products on the market today, […]
There are already a number of studies showing how cannabis use can curb opioid use, in relation to myriad ailments and conditions. […]
States that have legalized recreational marijuana use for adults have also seen a drop in mental health treatment admissions, according to newly […]